ストックスクリーナーアプリを入手
1.39
2.21%
0.03
アフターアワーズ：
1.37
-0.02
-1.44%
前日終値:
$1.36
開ける：
$1.38
24時間の取引高:
10,152
Relative Volume:
0.09
時価総額：
$16.31M
収益：
-
当期純損益:
$-3.15M
株価収益率:
-4.5544
EPS:
-0.3052
ネットキャッシュフロー:
$-2.23M
1週間 パフォーマンス:
-1.42%
1か月 パフォーマンス:
-21.47%
6か月 パフォーマンス:
-36.77%
1年 パフォーマンス:
-59.48%
1日の値動き範囲:
$1.34
$1.4001
1週間の範囲:
$1.29
$1.60
52週間の値動き範囲:
$1.29
$3.68
Cytomed Therapeutics Ltd Stock (GDTC) Company Profile
GDTC を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
GDTC
Cytomed Therapeutics Ltd
|
1.39 | 15.96M | 0 | -3.15M | -2.23M | -0.3052 |
|
VRTX
Vertex Pharmaceuticals Inc
|
468.38 | 113.87B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
776.54 | 80.22B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
406.40 | 52.56B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
803.74 | 49.31B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.07 | 37.37B | 447.02M | -1.18B | -906.14M | -6.1812 |
Cytomed Therapeutics Ltd (GDTC) 最新ニュース
Is CytoMed Therapeutics Limited stock attractive after correctionJuly 2025 Technicals & Expert-Curated Trade Recommendations - DonanımHaber
How CytoMed Therapeutics Limited (F98) stock performs in volatility spikes2025 Growth vs Value & Fast Entry and Exit Trade Plans - Улправда
Is CytoMed Therapeutics Limited stock a smart buy before Fed meeting2025 Valuation Update & Daily Profit Maximizing Trade Tips - Улправда
CytoMed Therapeutics (NASDAQ:GDTC) Trading Up 7.2% – Here’s Why - Defense World
CytoMed stock jumps after announcing clinical trial partnership in Malaysia By Investing.com - Investing.com South Africa
CytoMed stock jumps after announcing clinical trial partnership in Malaysia - Investing.com India
CytoMed Therapeutics enters clinical trial agreement with Malaysian hospital - Investing.com
CytoMed Therapeutics enters clinical trial agreement with Malaysian hospital By Investing.com - Investing.com South Africa
CytoMed Therapeutics (NASDAQ: GDTC) plans first-in-human gamma delta T cell trial in Malaysia - Stock Titan
CytoMed Therapeutics (NASDAQ: GDTC) to run first-in-human Malaysia trial of donor-derived γδ T cells - Stock Titan
CytoMed Therapeutics (GDTC) Stock Analysis Report | Financials & Insights - Benzinga
Why CytoMed Therapeutics Limited (F98) stock appears on watchlists2025 Price Momentum & Reliable Trade Execution Plans - Newser
Will CytoMed Therapeutics Limited (F98) stock benefit from Fed rate cuts2025 Short Interest & Intraday High Probability Setup Alerts - Newser
CytoMed acquires T Cell technology from UK to treat cancers in China and India - BioSpectrum Asia
CytoMed Therapeutics acquires T Cell technology from UK to treat cancers in China and India - BioSpectrum Asia
Applying Wyckoff theory to CytoMed Therapeutics Limited stock2025 Trade Ideas & Weekly Hot Stock Watchlists - newser.com
What earnings margins imply for CytoMed Therapeutics Limited (F98) stockQuarterly Trade Review & AI Driven Stock Movement Reports - newser.com
How CytoMed Therapeutics Limited stock reacts to job market dataPortfolio Update Summary & Daily Technical Stock Forecast Reports - newser.com
Can you recover from losses in CytoMed Therapeutics LimitedTrade Risk Report & AI Driven Stock Reports - newser.com
CytoMed Therapeutics Ltd (GDTC) can make a big difference with a little luck - Setenews
Will CytoMed Therapeutics Limited stock outperform Dow Jones indexJuly 2025 Short Interest & Entry Point Confirmation Alerts - newser.com
Why CytoMed Therapeutics Limited stock remains a top recommendationWatch List & Safe Entry Point Identification - newser.com
CytoMed acquires TC BioPharm’s gamma delta T cell technology By Investing.com - Investing.com Canada
How dovish Fed policy supports CytoMed Therapeutics Limited (F98) stock - newser.com
Can CytoMed Therapeutics Limited (F98) stock resist broad market declinesMarket Risk Summary & Daily Profit Focused Stock Screening - newser.com
What insider trading reveals about CytoMed Therapeutics Limited stockQuarterly Trade Review & High Win Rate Trade Tips - newser.com
Will CytoMed Therapeutics Limited (F98) stock maintain strong growthProduct Launch & Stepwise Trade Signal Implementation - newser.com
CytoMed acquires TC BioPharm's gamma delta T cell technology By Investing.com - Investing.com Nigeria
[6-K] CytoMed Therapeutics Ltd Current Report (Foreign Issuer) | GDTC SEC FilingForm 6-K - Stock Titan
Royal Caribbean (NYSE: RCL) launches unsecured notes sale to finance Celebrity Xcel - Stock Titan
Is CytoMed Therapeutics Limited (F98) stock a fit for income portfoliosMarket Risk Summary & Free Low Drawdown Momentum Trade Ideas - newser.com
Will CytoMed Therapeutics Limited (F98) stock keep high P E multiples2025 Key Lessons & Weekly Top Stock Performers List - newser.com
Is a relief rally coming for CytoMed Therapeutics Limited holdersMarket Activity Summary & Fast Gain Swing Alerts - newser.com
CytoMed Therapeutics Limited recovery potential after sell offJuly 2025 Highlights & Free Low Drawdown Momentum Trade Ideas - newser.com
Is CytoMed Therapeutics Limited (F98) stock undervalued historically2025 Market Outlook & Risk Managed Investment Signals - newser.com
How to monitor CytoMed Therapeutics Limited with trend dashboardsJuly 2025 Weekly Recap & Safe Swing Trade Setups - newser.com
Is CytoMed Therapeutics Limited stock attractive for income investorsMarket Risk Summary & Community Consensus Picks - newser.com
Is CytoMed Therapeutics Limited stock vulnerable to regulatory risksJuly 2025 Momentum & Technical Pattern Based Signals - newser.com
GDTC Stock Institutional Owners - Quiver Quantitative
CytoMed Therapeutics Limited (GDTC) Stock Price, News, Quote & History - Yahoo! Finance Canada
There is no way CytoMed Therapeutics Ltd (GDTC) can keep these numbers up - setenews.com
CytoMed Therapeutics secures $500,000 investment for subsidiary By Investing.com - Investing.com Nigeria
CytoMed Therapeutics Secures Non-Dilutive Investment for Subsidiary LongevityBank from ICH Capital and Updates on New China Strategy - The Manila Times
Cytomed Therapeutics Ltd (GDTC) 財務データ
収益
当期純利益
現金流量
EPS
2.52%
0.07%
大文字化:
|
ボリューム (24 時間):